Market Overview:
Extracorporeal Membrane Oxygenation Machine (ECMO) Market is anticipated to record a CAGR of 4.8% over 2019-2025 and amass an estimated revenue of USD 267.60 million by 2025.
Extracorporeal membrane oxygenation machine market has been registering increasing revenue as a result of several factors that include increasing use of ECMO machine for open heart surgeries or procedures that involve life threatening cardiovascular and respiratory diseases. Expanding geriatric population, rising prevalence of lung diseases, improvement in ECMO technology are expected to be other driving forces for the ECMO machine market over 2019-2025. Increasing number of hospitals and other medical facilities have been reported to have ECMO machines. For instance, in a 2017 report published by the World Health Organization, around 306 hospitals in the U.S. used ECMO machines for the treatment of lung and heart diseases. Additionally, there were 9385 instances of ECMO administration in U.S. hospitals in 2017.
ECMO machines are also known as life support machines. They are designed to oxygenate blood outside the patient’s body and allows the heart and lungs to rest. The ECMO machine works by taking the blood out of the body, into an artificial lung where it adds oxygen and removes carbon dioxide. The blood is then armed to body temperature and pumped back into the body.
Get Full Report Details with TOC Exclusively @ https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119
Key Players:
- Medtronic
- Siemens
- Abbott
- Getinge Group
- Agilent technologies
- Livanova PLC
- Terumo Corporation
- Nipro Corporation
- Fresenius Medical Care AG & Co
- ALung technologies
Segmentation:
- ECMO machine market divides the market on the basis of component, modality, application and region.
- ECMO machine consists of different components such as pumps, controllers, oxygenators, cannula and accessories. ECMO machine market has registered revenue growth on as each component segment has showed growth prospects as ECMO machines have come to be more widely used. Oxygenators segment is expected to record considerable CAGR over 2019-2025 and hold a major ECMO machine market share due to increased application ECMO machines in treatment of heart and lung diseases.
- On the basis of modality, ECMO machine market is further segmented as veno-arterial, arteries-venous and veno-venous.
- On the basis of region ECMO machine market is subdivided into Americas, Europe, Asia Pacific and MEA.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
Industry InsightsThe global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.Regional InsightsThe major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA.
Research report, Chosen the Global Extracorporeal Membrane Oxygenation Systems Industry, have now been published and offer a very thorough comprehension of the area.
This report is meant for cooperation and consists of secondary and primary research methods.
It covers areas of also to increase the operation of the businesses and companies.
The study report gives a comprehensive evaluation of the marketplace and contains meticulous opinions tendencies expansion factors statistics, factual and marketplace information that is supported.
Projections are revealed by regional exploration of this market.Request Sample Copy at: https://introspectivemarketresearch.com/request/272Key Player Mentioned: Maquet Holding, Medtronic, Terumo Medical, Medos Medizintechnik, Nipro Medical, Sorin Group, MicroPort ScientificProduct Segment Analysis: Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R)Application Segment Analysis: Respiratory, Cardia, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)Regional Segment Analysis: USA, Europe, Japan, China, India, South East AsiaA considerate and efficient strategy of activity for many organizations starts with an evaluation that is appropriate.
Market companies are expanding their operations through a spread of services beyond investment and development programs and buying processes.
